These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Aplastic anemia and agranulocytosis in patients using methazolamide for glaucoma. Werblin TP; Pollack IP; Liss RA JAMA; 1979 Jun; 241(26):2817-8. PubMed ID: 448845 [TBL] [Abstract][Full Text] [Related]
3. Aplastic anemia resulting from the use of carbonic anhydrase inhibitors. Wisch N; Fischbein FI; Siegel R; Glass JL; Leopold I Am J Ophthalmol; 1973 Jan; 75(1):130-2. PubMed ID: 4684255 [No Abstract] [Full Text] [Related]
4. Blood dyscrasias in patients using methazolamide (neptazane) for glaucoma. Werblin TP; Pollack IP; Liss RA Ophthalmology; 1980 Apr; 87(4):350-4. PubMed ID: 7393540 [TBL] [Abstract][Full Text] [Related]
5. Short-term use of carbonic anhydrase inhibitors and hematologic side effects. Fraunfelder FT; Fraunfelder FW Arch Ophthalmol; 1992 Apr; 110(4):446-7. PubMed ID: 1562240 [No Abstract] [Full Text] [Related]
6. Patient tolerance to carbonic anhydrase inhibitors. Lichter PR; Newman LP; Wheeler NC; Beall OV Am J Ophthalmol; 1978 Apr; 85(4):495-502. PubMed ID: 655230 [TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitor side effects. Serum chemical analysis. Epstein DL; Grant WM Arch Ophthalmol; 1977 Aug; 95(8):1378-82. PubMed ID: 889513 [TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitor-induced Stevens-Johnson syndrome/toxic epidermal necrolysis leads to extensive cutaneous involvement. Kim S; Yun J; Kang DY; Park HJ; Jo EJ; Jung JW; Park HK; Park JW; Jee YK; Kang HR; Lee JM J Allergy Clin Immunol Pract; 2019; 7(8):2851-2853.e2. PubMed ID: 31128378 [No Abstract] [Full Text] [Related]
16. Ocular hypotensive effects of carbonic anhydrase inhibitors in normotensive and glaucomatous Beagles. Gelatt KN; Gum G; Williams LW; Gwin RM Am J Vet Res; 1979 Mar; 40(3):334-45. PubMed ID: 475084 [TBL] [Abstract][Full Text] [Related]